Vascular Embolization Global Market Report 2024

The vascular embolization market size has grown strongly in recent years. It will grow from $2.89 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to the rising prevalence of vascular diseases, an increase in demand for non-coiling devices, a surge in the use of clot agents, and increased awareness about advanced treatment options for vascular conditions.

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period can be attributed to the growth in the cases of chronic diseases, increasing investments in R&D activities, a growing preference for minimally invasive procedures, geographic expansion and improved access to healthcare, and rising disposable incomes. Key trends expected in the forecast period include technological advancements, strategic collaborations, and the development of innovative vascular embolization devices within the industry.

The anticipated rise in the prevalence of vascular diseases is set to drive the growth of the vascular embolization market. Vascular diseases encompass various disorders affecting blood vessels, including arteries and veins, leading to reduced blood flow and various conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, and peripheral artery diseases. Vascular embolization serves as a treatment for these disorders, involving the occlusion or obstruction of blood vessels to address bleeding, repair aneurysms, and enhance blood supply in veins. As of April 2023, HMP Communications LLC reported a global prevalence of 21 million cases of peripheral artery diseases (PAD) in 2020, projected to reach 23.8 million by 2030. This underlines how the increasing prevalence of vascular diseases is a key driver for the vascular embolization market.

The high prevalence of chronic kidney diseases is also expected to contribute significantly to the growth of the vascular embolization market. Chronic Kidney Disease (CKD) involves gradual and irreversible damage to the kidneys over time. Vascular embolization is employed in CKD to halt bleeding from kidney tumors, arteriovenous malformations (AVMs), or complications from kidney biopsies or transplants. This approach avoids the risks associated with open surgery, particularly in patients with compromised kidney function. Notably, in Australia, from 2020 to 2021, around 2 million hospitalizations (17% of total admissions) were attributed to CKD, emphasizing the considerable impact of this condition. The prevalence of chronic kidney diseases is a driving force behind the growth of the vascular embolization market.

A prominent trend in the vascular embolization market is the adoption of technological advancements by major companies. These innovations are geared towards sustaining their market positions and enhancing the effectiveness of vascular embolization procedures. For example, in June 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, introduced the Pipeline Vantage, a flex embolization device designed for the treatment of brain aneurysms. This device incorporates shield technology and features improved delivery design characteristics, making it more reliable for clinicians to transport, deploy, and treat brain aneurysms.

Major companies in the vascular embolization market are focusing on developing innovative products such as embolic systems to drive profitability. Embolic systems, comprising embolic agents and delivery devices, are utilized to intentionally block blood vessels in medical procedures. In October 2023, Sirtex Medical launched the Lava liquid embolic system (LES), offering a versatile solution for controlled target vessel occlusion in peripheral vasculature. Its varied viscosity options enable effective distal embolization of small and hard-to-reach vessels, providing physicians with enhanced treatment options.

In August 2022, Boston Scientific Corporation acquired Obsidio. This acquisition aims to expand Boston Scientific Corporation's interventional oncology and embolization portfolio, offering unique options for physicians and patients dealing with hemorrhages, cancer, and other debilitating conditions. Obsidio specializes in minimally invasive blood vessel occlusion.

Major companies operating in the vascular embolization market report are Johnson and Johnson Co, Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

North America was the largest region in the vascular embolization market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular embolization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The main products associated with vascular embolization are embolic agents and embolization devices. Embolic agents are chemicals or materials injected or placed in specific regions to block or occlude blood vessels, effectively treating various medical conditions. These agents are utilized in different procedures to address medical issues such as tumors, aneurysms, and arteriovenous malformations (AVMs). Various embolization techniques include coiling devices and non-coiling devices, applied in diverse medical applications such as peripheral vascular diseases, oncology, urology, neurology, and others. These products cater to various end-users, including hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

The vascular embolization market research report is one of a series of new reports that provides vascular embolization market statistics, including vascular embolization industry global market size, regional shares, competitors with a vascular embolization market share, detailed vascular embolization market segments, market trends and opportunities, and any further data you may need to thrive in the vascular embolization industry. This vascular embolization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular embolization market consists of revenues earned by entities by providing vascular embolization techniques such as chemoembolization or radioembolization, sac packing, sandwich technique, stent-assisted coiling, and particle embolization. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular embolization market also includes sales of balloons, gelatin foam, liquid glue, liquid sclerosing agents, particulate agents, detachable coils, and push able coils. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.